| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
In8bio, Inc. (INAB) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. INAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 724.6K | $1.09M | - | |
| CEO | 206.0K | $309.0K | - | |
| ? | 95.2K | $142.8K | - | |
| COO | 80.0K | $120.0K | - | |
| CFO | 75.0K | $112.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Roemer Alan S. | Director | Buy | 26,315 | $1.90 | $49,998.50 | +88.7% | -19.6% | -37.0% | |
| Aug 16, 2022 | Greenwood Luba | Director | Buy | 526 | $1.90 | $999.40 | +7.2% | -19.6% | -37.0% | |
| Aug 3, 2021 | Fairbairn Emily | Director, 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +3.1% | -22.2% | -75.4% |